CAAN-AF Trial #CHRD@adelaide87018
Our previous meta-analysis of observational studies suggested CRT patients with AF had a significant 58% reduction in all-cause mortality with AV node ablation - https://t.co/rLbkUhqZLX
We designed the CAAN AF Trial supported by the @nhmrc and critical industry partners - in order of support @bostonsci@AbbottNews@Medtronic@MicroPort - Methodology paper - https://t.co/kZrLVV9G9q
CAAN AF Trial: https://t.co/bMIaH2CPHV
RCT showing no benefit in the routine use of AV node ablation
Among patients with #AtrialFibrillation, elevated BMI, and 1 or more additional cardiometabolic risk factors, aggressive risk factor management reduced arrhythmia recurrence over the 12-month period after catheter ablation. https://t.co/SYBBFqrFog
📢 APHRS Summit 2026 – Registration Open!
📍 Auckland, NZ | 🗓 28 Feb 2026
Join APAC leaders in heart rhythm care for a full day on AF ablation, pacing, EP innovations & more.
🔗 Register: https://t.co/gNHz7uhdf0
#APHRSSUMMIT2026#HeartRhythm#EP#Cardiology#Auckland
💥 428. AF: The Impact of Modifiable Risk Factors and Lifestyle Management – with Dr. Prash Sanders
🎧 https://t.co/ZDZFmMZ4Bz
Join us at #AHA25 ❤️ @AHAScience
🔗 Register: https://t.co/4WwgcyAPFn
Presented at #AHA25:
In patients with atrial fibrillation after successful ablation, rivaroxaban therapy did not lead to a significantly lower incidence of a composite of stroke, systemic embolism, or new covert embolic stroke than aspirin therapy. Full OCEAN trial results: https://t.co/jM3DdE3mUS
@AHAScience
⚠️ Know the difference: #Suddencardiacarrest (SCA) isn't a heart attack — it's when your heart's electrical system suddenly fails, stopping your heartbeat instantly. Without immediate action, brain damage or death can occur within minutes.
This is why recognizing the signs of SCA and knowing #CPR can save a life. Learn more this #SCAAwarenessMonth 👉 https://t.co/sRIle8CLwY
#CPRSavesLives #hearthealth #UpBeatbyHRS @hrsonline
NEW EPISODE OF THE LEAD!
[Ep. 124] A Discussion of Catheter Ablation vs Lifestyle Modification With Antiarrhythmic Drugs to Treat Atrial Fibrillation: PRAGUE 25 Trial, LIVE at HRX
🎙️ Host: Danesh Kella, MBBS, FHRS
🎤 Guests: Ratika Parkash (@ratika_parkash), MD, MS, FHRS and Prashanthan Sanders, MBBS, PhD, FHRS (@PrashSanders)
Listen on your preferred podcast platform
➡️ https://t.co/VXfAm8TCpL
#EPeeps #medpod #podcast #CardioTwitter #EPTwitter #PodcastAndChill
@Vortex_mapper presenting on #Afib mapping
We need to learn from other systems in nature to map #Afib
Great to see the work continuing to improve patient care
#CHRD#AFsymposium@UniofAdelaide
Prof. @PrashSanders has opened the Centre for Heart Rhythm Disorders 20th Anniversary Symposium 👏🏻
Looking forward to 2 days of scientific content highlighting 20 years of research in Atrial Fibrillation @UniofAdelaide
🏃🏻♀️Exercise, 🍷 alcohol & obesity
What do patients with AF need to know?
Could your AF be masking something else?
@Elliott_AD@JonathanAriya@WongChrisX and Sam Tu will unpack the evidence this Friday at the CHRD Symposium
👉https://t.co/Wg7GJZljGE
#AtrialFibrillation
Prof Bobby John speaking on his transformational work on valvular heart disease and #Afib
This was my “light bulb” moment that the AF substrate may be reversible
#CHRD#AFsymposium@UniofAdelaide
doi: 10.1016/j.jacc.2009.10.046
Dr Bobby John, the first PhD candidate at the Centre for Heart Rhythm Disorders (2004) presenting on the relationship between Valve Disease and Atrial Fibrillation, and acknowledging the generous patient contribution in this research #CHRDSymposium@PrashSanders